Original Research and the Latest News

How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%

by | January 16, 2026 | New Technology, Probability of Success | 0 Comments

Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success (POS) forecasting can revolutionize the landscape of clinical trials. By adopting next-gen POS forecasting models, companies can...

Not Your Grandparents’ Probability of Success Forecasts

by | November 9, 2025 | New Technology, Probability of Success | 0 Comments

Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and analytics, traditional Probability of Success (POS) forecasts are a familiar, yet often frustrating approach to assessing clinical risk. While...

Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

by | October 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success | 0 Comments

The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength.Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...

Clinical Trial Success Rates: What Makes Some Companies Stand Out?

by | October 9, 2025 | New Technology, Probability of Success | 0 Comments

Our comprehensive analysis of over 30,000 clinical trials across more than 4,000 biopharmaceutical companies reveals significant variations in clinical trial success rates. This disparity exists even among trials in the same phase and targeting the same disease,...

Recent Posts

We’re Back!

Oct 27, 2017 |

Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have...

Recent Tweets

Ozmosi Follow

BioPharma/Biotech Intel. Daily $XBI $XPH Market Movers Database: https://t.co/IBOqbSoYuc Clinical trial tools: https://t.co/A77u9Q84Dc https://t.co/AQERg9nHrb

OzmosiHealth
ozmosihealth Ozmosi @ozmosihealth ·
8 Jun

$SPRB

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium

More Info: https://pryzm.ozmosi.com/product/24964

Reply on Twitter 2064090855892500840 Retweet on Twitter 2064090855892500840 1 Like on Twitter 2064090855892500840 1 Twitter 2064090855892500840
ozmosihealth Ozmosi @ozmosihealth ·
8 Jun

$LLY

Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials

More Info: https://pryzm.ozmosi.com/product/21351

Reply on Twitter 2064090853032026181 Retweet on Twitter 2064090853032026181 Like on Twitter 2064090853032026181 Twitter 2064090853032026181
ozmosihealth Ozmosi @ozmosihealth ·
8 Jun

$IPSC

New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

More Info: https://pryzm.ozmosi.com/product/37695

Reply on Twitter 2064090850238607525 Retweet on Twitter 2064090850238607525 Like on Twitter 2064090850238607525 Twitter 2064090850238607525
ozmosihealth Ozmosi @ozmosihealth ·
8 Jun

$NBIX +nan% today

Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities

More Info: https://pryzm.ozmosi.com/product/2327

Reply on Twitter 2063985099277000836 Retweet on Twitter 2063985099277000836 Like on Twitter 2063985099277000836 Twitter 2063985099277000836
Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

Get in Touch

info@ozmosi.com
(732) 701-7807

600 Warren Ave,
Spring Lake, NJ 07762